Publications by authors named "M Levis"

Claim this Profile
P
Post-HCT maintenance therapy for AML: who, when, why, how long?
Mark Levis

Hematology Am Soc Hematol Educ Program· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Radiotherapy for Primary Cutaneous Indolent B-Cell Lymphomas: a Multicenter Retrospective Study.
E Alì, G Simontacchi, M Levis, F Iori, S Gambara

Radiother Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The best laid schemes..
Mark J Levis

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML.
Theodoros Karantanos, Nour Naji, Taha Ahmedna, J Peske, Xinghan Zeng, Mark Levis

Res Sq· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis